The Functional Crosstalk between HER2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy.
about
Monoclonal antibodies for the treatment of cancerTwo faces of TGF-beta1 in breast cancer.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancerTumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility.A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.Fucose-containing fraction of Ling-Zhi enhances lipid rafts-dependent ubiquitination of TGFβ receptor degradation and attenuates breast cancer tumorigenesisPhytoestrogenic activity of blackcurrant (Ribes nigrum) anthocyanins is mediated through estrogen receptor alpha.MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients.The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer.The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment.Cancer stem cells and HER2 positive breast cancer: The story so far
P2860
Q27025966-CA9ACC28-E1A3-402C-8EDB-0CD25879C270Q33661529-3AFD5F1F-8249-45D9-872E-1ACDF526B1E7Q33737278-7BCEE2EE-2817-4E79-874C-3F13B33527C4Q34614133-0374F3F8-DE03-411D-8607-E90721350F96Q35016950-571823CC-64A4-4DBE-BF54-BB070C3FD45DQ35793883-28A1AF71-B782-4D58-A95E-5C90F15E16C1Q35803226-2C2F1E63-B850-4AB9-9D0F-010F5ACC39E5Q36119638-9E16B832-575D-4C75-AFE6-8EF8B970F851Q36186223-C2387323-C442-44E3-9B41-D5A23E2FD6E6Q37405583-A9E98E02-E310-4283-8473-CC63C8A13BDFQ38833476-92B17892-7516-4A9D-9B55-86FD7638990DQ39016680-2AB88B9C-A4DE-4EDF-B64F-8CFCCB922951Q39614413-4C92C7F7-4A62-48EA-9A0B-2D305F4963A2Q47179544-7E20D38C-C47F-4E96-A1A8-25A1A9EC8BB1Q48093934-DE47B6DC-12A4-480A-9561-EDACF1B07615Q57120564-3A90243E-A7DC-4199-9260-08E019C46C50
P2860
The Functional Crosstalk between HER2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
The Functional Crosstalk betwe ...... g in Breast Cancer Malignancy.
@ast
The Functional Crosstalk betwe ...... g in Breast Cancer Malignancy.
@en
type
label
The Functional Crosstalk betwe ...... g in Breast Cancer Malignancy.
@ast
The Functional Crosstalk betwe ...... g in Breast Cancer Malignancy.
@en
prefLabel
The Functional Crosstalk betwe ...... g in Breast Cancer Malignancy.
@ast
The Functional Crosstalk betwe ...... g in Breast Cancer Malignancy.
@en
P2860
P356
P1476
The Functional Crosstalk betwe ...... g in Breast Cancer Malignancy.
@en
P2093
Shizhen Emily Wang
P2860
P304
P356
10.1155/2011/804236
P577
2011-02-24T00:00:00Z